Search

everythinglearnresearchcommunity

for

Search:↓

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Sex hormones affect brain cells differently in males and females.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

More research needed to confirm finasteride as standard treatment for FFA.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.